✦ LIBER ✦

Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen

✍ Scribed by Mario Campone; Loïc Campion; Henry Roché; Wilfried Gouraud; Catherine Charbonnel; Florence Magrangeas; Stéphane Minvielle; Jean Genève; Anne-Laure Martin; Régis Bataille; Pascal Jézéquel

Book ID: 106377563
Publisher: Springer US
Year: 2007
Tongue: English
Weight: 238 KB
Volume: 109
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-007-9673-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

10-year follow-up update of French adjuv

10-year follow-up update of French adjuvant study group 05 trial: FEC 100 regimen remains superior to FEC 50 in adjuvant chemotherapy of poor prognosis, node-positive, early breast cancer patients

✍ V. Servent; J. Bonneterre; H. Roché; P. Kerbrat; A. Brémond; P. Fumoleau; M. Nam 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 192 KB

A phase III adjuvant randomised trial of

A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil–epirubicine–cyclophosphamide (FEC100) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000)

✍ Delbaldo, C.; Serin, D.; Mousseau, M.; Greget, S.; Audhuy, B.; Priou, F.; Berdah 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 761 KB

A prognostic model of early breast cance

A prognostic model of early breast cancer relapse after standard adjuvant therapy and comparison with metastatic disease on initial presentation

✍ Li Chen, Edward Romond, Saurin Chokshi, Hayder Saeed, Jacob Hodskins, Mark Steve 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 233 KB

2100 ORAL Prediction of brain relapse (B

2100 ORAL Prediction of brain relapse (BR) in HER-2 positive metastatic breast cancer (MBC) patients (pts)

✍ R. Duchnowska; B. Czartoryska-Arlukowicz; B. Radecka; B. Szostakiewicz; K. Sosin 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Long-term Cardiac Follow-up in Relapse-F

Long-term Cardiac Follow-up in Relapse-Free Patients After Six Courses of Fluorouracil, Epirubicin, and Cyclophosphamide, With Either 50 or 100 mg of Epirubicin, as Adjuvant Therapy for Node-Positive Breast Cancer: French Adjuvant Study Group

✍ Shapiro, C.L. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 56 KB

A 38-gene expression signature to predic

A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial

✍ Pascal Jézéquel; Mario Campone; Henri Roché; Wilfried Gouraud; Catherine Charbon 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 469 KB